Chemoinformaics analysis of METHYL 2-HYDROXY-5-(4-HYDROXY-3-METHOXYCARBONYLPHENOXY)BENZOATE
| Molecular Weight | 318.281 | nRot | 4 |
| Heavy Atom Molecular Weight | 304.169 | nRig | 14 |
| Exact Molecular Weight | 318.074 | nRing | 2 |
| Solubility: LogS | -3.877 | nHRing | 0 |
| Solubility: LogP | 4.183 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 41.6691 |
| nHD | 2 | BPOL | 20.9889 |
| QED | 0.835 |
| Synth | 2.014 |
| Natural Product Likeliness | -0.041 |
| NR-PPAR-gamma | 0.029 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0 |
| HIA | 0.025 |
| CACO-2 | -4.751 |
| MDCK | 0.0000394 |
| BBB | 0.501 |
| PPB | 0.986538 |
| VDSS | 0.459 |
| FU | 0.0371409 |
| CYP1A2-inh | 0.949 |
| CYP1A2-sub | 0.808 |
| CYP2c19-inh | 0.95 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.858 |
| CYP2c9-sub | 0.941 |
| CYP2d6-inh | 0.658 |
| CYP2d6-sub | 0.71 |
| CYP3a4-inh | 0.609 |
| CYP3a4-sub | 0.163 |
| CL | 12.923 |
| T12 | 0.875 |
| hERG | 0.025 |
| Ames | 0.138 |
| ROA | 0.048 |
| SkinSen | 0.369 |
| Carcinogencity | 0.886 |
| EI | 0.898 |
| Respiratory | 0.089 |
| NR-Aromatase | 0.663 |
| Antiviral | Yes |
| Prediction | 0.718152 |